The biology of incretin hormones

Cell Metabolism
Daniel J Drucker

Abstract

Gut peptides, exemplified by glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are secreted in a nutrient-dependent manner and stimulate glucose-dependent insulin secretion. Both GIP and GLP-1 also promote beta cell proliferation and inhibit apoptosis, leading to expansion of beta cell mass. GLP-1, but not GIP, controls glycemia via additional actions on glucose sensors, inhibition of gastric emptying, food intake and glucagon secretion. Furthermore, GLP-1, unlike GIP, potently stimulates insulin secretion and reduces blood glucose in human subjects with type 2 diabetes. This article summarizes current concepts of incretin action and highlights the potential therapeutic utility of GLP-1 receptor agonists and dipeptidyl peptidase-4 (DPP-4) inhibitors for the treatment of type 2 diabetes.

References

May 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·D J DruckerJ F Habener
Jun 1, 1997·European Journal of Clinical Investigation·J F ToddS R Bloom
Apr 29, 1998·The Journal of Clinical Investigation·J SchirraM Katschinski
Dec 28, 1999·Proceedings of the National Academy of Sciences of the United States of America·K MiyawakiY Seino
May 24, 2000·Proceedings of the National Academy of Sciences of the United States of America·D MarguetN Wagtmann
Sep 27, 2000·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·B Balkan, X Li
Nov 1, 2000·Nature Cell Biology·N OzakiS Seino
Jun 8, 2001·Biochemical and Biophysical Research Communications·T NagakuraI Tanaka
Oct 13, 2001·The Journal of Biological Chemistry·Y KashimaS Seino

❮ Previous
Next ❯

Citations

Mar 16, 2007·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Dominique Bataille
Aug 13, 2008·Diabetologia·T Jin
Sep 21, 2010·Naunyn-Schmiedeberg's Archives of Pharmacology·Hui-Chun KuMing-Jai Su
Jul 13, 2011·Naunyn-Schmiedeberg's Archives of Pharmacology·Hui-Chun KuMing-Jai Su
Nov 26, 2009·European Journal of Nutrition·Katharina S KuhnPeter Stehle
Sep 6, 2011·Basic Research in Cardiology·Yumei YeYochai Birnbaum
Sep 9, 2008·Reviews in Endocrine & Metabolic Disorders·K J Chang-ChenE Bernal-Mizrachi
Mar 12, 2011·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Brett M ConnollyEric Hostetler
Nov 19, 2011·Obesity Surgery·Priscila C SalaDan L Waitzberg
Apr 29, 2010·Current Diabetes Reports·Dima L Diab, David A D'Alessio
Aug 21, 2013·Current Diabetes Reports·Jeff Unger
Aug 9, 2013·Current Diabetes Reports·Joachim Storling, Caroline Anna Brorsson
Jan 17, 2009·Current Hypertension Reports·Derek D Mafong, Robert R Henry
Jan 29, 2013·Endocrine·Sachin K Majumdar, Silvio E Inzucchi
Oct 28, 2010·Advances in Therapy·David C Klonoff
Feb 21, 2013·Advances in Therapy·Michael HorowitzKaren L Jones
Dec 1, 2011·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Jeffrey R Unger, Christopher G Parkin
Dec 1, 2011·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Rupa Ahluwalia, Jiten Vora
Apr 12, 2007·Endocrinology and Metabolism Clinics of North America·Robert Ratner
Oct 26, 2011·The British Journal of Nutrition·Adrian K Hewson-HughesAndrew T Miller
Jul 8, 2011·The British Journal of Nutrition·Christine M BruenLinda Giblin
Nov 24, 2012·Nutrition Research Reviews·Andoni LanchaJavier Gómez-Ambrosi
Dec 7, 2013·Journal of Medicinal Chemistry·Jing HanWenlong Huang
Jul 6, 2013·Experimental & Molecular Medicine·Tae Jung OhYoung Min Cho

❮ Previous
Next ❯

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Anorexia Nervosa

Anorexia nervosa (AN) is a psychiatric condition characterized by severe weight loss and secondary problems associated with malnutrition. Here is the latest research on AN.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Calcium & Bioenergetics

Bioenergetic processes, including cellular respiration and photosynthesis, concern the transformation of energy by cells. Here is the latest research on the role of calcium in bioenergetics.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.